人类胎儿骨髓和唐氏综合征中的血液和免疫发育
Laura Jardine1,2, Simone Webb1, Issac Goh1
1Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Nature
|September 30, 2021
概括
胎儿骨髓 (BM) 在怀孕第二个三个月的早期迅速发展出一系列的血液和免疫细胞. 这项研究揭示了胎儿的BM发育及其对唐氏综合征的改变.
科学领域:
- 发育生物学
- 血液学
- 免疫学
背景情况:
- 骨髓中的血液形成对于血液和免疫细胞的产生至关重要.
- 胎儿骨髓 (FBM) 的发展及其对胎儿和新生儿健康的作用在很大程度上是未知的.
- 了解FBM的发展是理解早期人类造血的关键.
研究的目的:
- 调查胎儿骨髓 (FBM) 的发育轨迹,包括其结构组成部分.
- 在人类早期发展过程中描述FBM的多原子景观.
- 为了确定FBM,胎儿肝脏和带血的造血原体之间的差异.
主要方法:
- 在FBM中对mRNA和多重蛋白质表位的多组评估.
- 来自胎儿肝脏,FBM和带血液的血液生成原体的比较分析.
- 在FBM中研究血管结构和微环境.
主要成果:
- 在FBM中建立完整的血液和免疫细胞库在第二个三个月的6-7周内.
- 支持广泛的骨髓细胞多样化,包括新型颗粒细胞,乙酸细胞和树突细胞子集.
- 与胎儿肝脏相比,FBM中的B淋巴细胞显著扩张;观察到明显的血管分离.
- 造血原体表现出特定组织的转录和功能差异.
- 由于内在和外在因素,唐氏综合征 (三形) 与B淋巴细胞,红细胞和骨髓细胞发育中断有关.
结论:
- 胎儿骨髓 (FBM) 在孕期早期经历快速和全面的发育,形成全方位的血液和免疫细胞.
- FBM的独特细胞和微环境特征有助于胎儿和新生儿的血液形成.
- 在FBM发育和微环境的变化与唐氏综合征 (三形) 中观察到的血液异常有关.
相关概念视频
01:20Overview of Hematopoiesis
5.4K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
5.4K
01:01Regulation of Hematopoietic Stem Cells
3.5K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.5K
01:22Development of Immunocompetence
516
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
516
01:21Hematopoiesis
7.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.1K
01:22Bone Marrow Sampling and Transplants
570
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
570
01:28Role of Hematopoietic Growth Factors
1.9K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.9K